ロード中...
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Oncolytic viruses (OV) are a class of antitumor agents that selectively kill tumor cells while sparing normal cells. Oncolytic herpes simplex virus (oHSV) has been investigated in clinical trials for patients with the malignant brain tumor glioblastoma for more than a decade. These clinical studies...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4064532/ https://ncbi.nlm.nih.gov/pubmed/24999342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2014.00303 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|